CYP cynata therapeutics limited

Ann: Investor Presentation, page-330

  1. 216 Posts.
    lightbulb Created with Sketch. 35
    At that time Bazsa, Mesoblast deal with Oaktree meant giving away a 15% interest rate with ZIRP at time that made Mesoblast valueless and took whatever they could to survive, a mind numbingly bad deal that pledged ALL their IP to Hercules with very little to show for it as you have found out. Millions spent in interest rates and a cash balanced required throughout which crippled MSB. A basket case given the useless manufacturing IP MSB hold which NO ONE will want in future, hence zero IP deals.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.0¢
Change
0.000(0.00%)
Mkt cap ! $36.15M
Open High Low Value Volume
16.0¢ 16.5¢ 16.0¢ $14.06K 87.07K

Buyers (Bids)

No. Vol. Price($)
1 46112 16.0¢
 

Sellers (Offers)

Price($) Vol. No.
16.5¢ 55253 4
View Market Depth
Last trade - 12.24pm 26/06/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.